Reprint

Pathogenesis of Pregnancy-Related Complication

Edited by
April 2023
352 pages
  • ISBN978-3-0365-7327-4 (Hardback)
  • ISBN978-3-0365-7326-7 (PDF)

This book is a reprint of the Special Issue Pathogenesis of Pregnancy-Related Complication that was published in

Biology & Life Sciences
Chemistry & Materials Science
Medicine & Pharmacology
Summary

In this Special Issue, "Pathogenesis of Pregnancy-Related Complications", 4 reviews, 13 original papers, 1 communication, and 1 case report are compiled. These papers were published by scientific teams from 24 countries, including China, Tunisia, Canada, France, Serbia, Portugal, Spain, Chile, Singapore, Australia, the USA, Mexico, the Czech Republic, Germany, Sweden, Finland, the United Kingdom, Norway, Poland, Greece, Japan, Italy, Switzerland, and Israel, which is a really great achievement.

Format
  • Hardback
License
© by the authors
Keywords
pregnancy-induced CVD; chronic venous disease; proinflammatory cytokines; hypertensive vascular disorder; MeSH; preeclampsia; MenSCs; trophoblast invasion; galectin; maternal–fetal interface; pathologic pregnancy; preeclampsia; gestational diabetes mellitus; fetal growth restriction; preterm birth; preeclampsia; FGF2; angiogenesis; oxidative stress; L-NAME; gene expression; placenta; cardiovascular microRNAs; early pregnancy; gene expression; gestational diabetes mellitus; prediction; screening; whole peripheral venous blood; chorionic villus sampling; congenital malformations; placenta; prenatal testing transcriptome sequencing; endometriosis; pyroptosis; PGE2; cell migration; placenta; glucose uptake; SLC2A3; SLC2A1; insulin; glucagon; infertility; assisted reproductive technology; implantation failure; endometrium immunomodulation; blood–brain barrier; endothelium; fetal growth restriction; fetal hypoxia; neuronal damage; tight junctions; tight junction proteins; IL-6; IL-8; inflammation; pregnancy; pregnancy complications; microRNAs; miRNAs; small RNA sequencing; small RNA-seq; sPTD; miR-23b-5p; miR-125a-5p; miR-4732-5p; primary hyperparathyroidism; forensic; pulmonary metastatic calcification; B cells; idiopathic recurrent pregnancy loss; reproductive immunology; meta-analysis; MeSH; ficolin-2; FCN2; newborn; neonate; prematurity; single nucleotide polymorphism; very low birthweight; diabetes mellitus; human; placenta; pregnancy; RNA sequencing; CD24; preeclampsia; placental-derived immortalized cells; JEG-3 cells; BeWo cells; STOX1-A/B; in vitro preeclampsia models; immune tolerance; fetal growth restriction; human; placenta; amino acid transporters; SLC38A1; SLC38A2; SLC38A4; ischemic placental syndrome; preeclampsia; fetal growth restriction; soluble endoglin (sEng); soluble fms-like tyrosine kinase-1 (sFlt-1); placental growth factor (PlGF); sFlt-1/PlGF and sFlt-1*sEng/PlGF ratios; pregnancy adverse outcomes; n/a